文献速递关节外科

Zenith全踝关节置换术的中期疗效:单中心连续118例报告

Total ankle arthroplasty.
PubMed 文献 · Bone Joint J · 2021-01-01

本研究回顾性分析单中心连续118例Zenith全踝关节置换术的中期结果,平均随访5.1年,10例假体失败需翻修,7年假体生存率88.2%,患者报告结局和满意度显著改善,但踝部骨折、伤口愈合问题和浅表感染等并发症常见。

要点

  • 7年假体生存率88.2%,翻修主要原因为无菌性松动。
  • MOXFQ和VAS评分显著改善,总体满意度89%。
  • 常见并发症包括踝部骨折(14.4%)、伤口愈合问题(13.6%)和浅表感染(12.7%)。

核心结论

  • Zenith全踝关节置换术的中期生存率与其他假体和英国国家关节登记中心数据相当,患者满意度和功能结局较高。

研究设计与样本

  • 单中心、非设计者开展的连续病例系列,纳入2010年12月至2016年5月间植入的118例Zenith全踝关节置换术,共114例患者。

主要发现

  • 10例假体失败(8.5%)需翻修,7年以翻修为终点的假体生存率为88.2%(95%CI 100%至72.9%)。
  • MOXFQ平均从85.0改善至32.8,VAS从7.0改善至3.2,总体满意度89%。
  • 最常见并发症为踝部骨折(14.4%,n=17)、伤口愈合问题(13.6%,n=16)和浅表感染(12.7%,n=15)。
  • 翻修最常见原因为无菌性松动,无因深部感染翻修的病例。

临床怎么用

  • Zenith全踝关节置换术可作为踝关节炎的治疗选择之一,但需注意踝部骨折、伤口愈合和感染等并发症。

局限性

  • 本研究为单中心连续病例系列,非随机对照设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: We report the medium-term outcomes of a consecutive series of 118 Zenith total ankle arthroplasties (TAAs) from a single, non-designer centre. METHODS: Between December 2010 and May 2016, 118 consecutive Zenith prostheses were implanted in 114 patients. Demographic, clinical, and patient-reported outcome measures (PROMs) data were collected. The endpoint of the study was failure of the implant requiring revision of one or all of the components. Kaplan-Meier survival curves were generated with 95% confidence intervals (CIs) and the rate of failure calculated for each year. RESULTS: Eight patients (ten ankles) died during follow-up, but none required revision. Of the surviving 106 patients (108 ankles: rheumatoid arthritis (RA), n = 15; osteoarthritis (OA), n = 93), 38 were women and 68 were men, with a mean age of 68.2 years (48 to 86) at the time of surgery. Mean follow-up was 5.1 years (2.1 to 9.0). A total of ten implants failed (8.5%), thus requiring revision. The implant survival at seven years, using revision as an endpoint, was 88.2% (95% CI 100% to 72.9%). There was a mean improvement in Manchester-Oxford Foot and Ankle Questionnaire (MOXFQ) from 85.0 to 32.8 and visual analogue scale (VAS) scores from 7.0 to 3.2, and overall satisfaction was 89%. The three commonest complications were malleolar fracture (14.4%, n = 17), wound healing (13.6%, n = 16), and superficial infection (12.7%, n = 15). The commonest reason for revision was aseptic loosening. No patients in our study were revised for deep infection. CONCLUSION: Our results show that Zenith survival rates are comparable with those in the literature for other implants and in the National Joint Registry (NJR). Overall patient satisfaction was high as were functional outcomes. However, the data highlight potential complications associated with this surgery. The authors believe that these figures support ankle arthroplasty as an option in the treatment of ankle arthritis. Cite this article: Bone Joint J 2021;103-B(4):696-703.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Clough TM, Ring J. Total ankle arthroplasty. Bone Joint J. 2021. PMID: 33789488. doi:10.1302/0301-620X.103B4.BJJ-2020-0758.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。